Radiotherapy Market is Growing at a Healthy CAGR of 4.7% During Forecast to 2025
MRFR has published Stagnant
Analysis on “Radiotherapy Market –Global
Forecast to 2025”
Market Analysis:
Various factors are
propelling the radiotherapy market growth. Some of these factors, according to
the Market Research Future report, include increasing use of particle therapy
to treat cancer, a growing number of symposia and conferences to spread awareness
about the perks of radiotherapy, growing incidence of cancer, and various
technological advancements. Additional factors pushing market growth include
the improving reimbursement scenario and growing private and government
investments to cater to the burgeoning demand for cancer treatment.
The global Radiotherapy
Market Report is predicted to grow at a 4.7%
CAGR between 2019-2025, states
the latest Market Research Future (MRFR) report. Radiation therapy, simply put,
is a method used to treat cancer and also noncancerous growths, blood
disorders, and thyroid disease. This therapy uses high-energy waves or
particles such as protons, electron beams, gamma rays, and x-rays to damage or
destroy cancer cells.
On the flip side, the
lack of the latest infrastructure facilities, dearth of skilled healthcare
professionals, complexities related to radiotherapy procedures, and high cost
are factors that may hamper the radiotherapy market growth over the forecast
period.
Key Players:
ProTom International (US), ProNova Solutions LLC (US), Sumitomo
Heavy Industries Ltd. (Japan), Hitachi Ltd. (Japan), TechnicasRadiofiscas S.L
(Spain), PRECISIS AG (Germany), Brainlab AG (Germany), CIVCO Medical Solutions
(US), Mitsubishi Electric Corporation (Japan), Mevion Medical Systems, Inc.
(US), RaySearch Laboratories (Sweden), Isoray Medical, Inc. (US), C. R. Bard,
Inc. (US), Nordion, Inc. (Canada), Ion Beam Applications (IBA) (Belgium),
Accuray Incorporated (US), Elekta AB (Sweden), Varian Medical Systems, Inc.
(US), Hologic (US), Shimadzu Corporation (Japan), Philips Healthcare (US), Fuji
Holdings (Japan), View Ray (US), Nordion (CA), Cardinal Health (US), Siemens
(Germany), and GE Healthcare (UK).
Market Segmentation:
The MRFR report provides
an all-inclusive segmental analysis of the Radiotherapy
Market on the basis of application and treatment type.
Based on treatment type,
the radiotherapy market is segmented into internal radiation therapy, proton therapy,
external beam radiotherapy, gamma-ray, and x-ray. The external beam
radiotherapy segment is again segmented into stereotactic body radiation
therapy, stereotactic radiosurgery, tomotherapy, image-guided radiation
therapy, intensity-modulated radiation therapy, and 3D conformal radiation
therapy. Of these, the external beam radiotherapy segment will lead the market
over the forecast period on account of the increased accuracy and precision of
tumor targeting in the therapy and reduced risk of exposure to radiation in the
external beam radiotherapy.
Based on the
application, the radiotherapy market is segmented into thyroid, ovarian cancer,
lung and breast cancer, and prostate cancer. Of these, the prostate cancer
segment will dominate the market over the forecast period on account of growing
diagnosis as well as treatment rate of the disease, increasing incidence of
prostate cancer along with related mortality, and growing awareness about the
benefits and fatality of early diagnosis as well as treatment worldwide.
Regional Analysis:
By region, the
radiotherapy market report covers the latest trends and growth opportunities
across the Europe, the Middle East and Africa, the Asia Pacific, and the
Americas. Of these, the Americas will lead the market over the forecast period
on account of growing technological advancements. The US is the leading
contributor in this region owing to the adoption of the latest technology and
increasing cancer patients.
The radiotherapy market
in Europe is predicted to have the second-largest share in the market over the
forecast period on account of increasing research and development. This region
has its own medical regulations. Besides, government bodies are investing more
in the healthcare sector, coupled with the adoption of sophisticated and new
technologies are also adding to the market growth.
Access Full Report
Details @ https://www.marketresearchfuture.com/reports/radiotherapy-market-1526
The radiotherapy market
in the APAC region is predicted to grow at the fastest pace over the forecast
period for the growing consumption of tobacco and governments focusing on
improving the healthcare sector. In this region, research and development are
also increasing owing to the presence of key players. Besides, the burgeoning
number of patients suffering from thyroid, and oral and
lung cancer are also adding to the market growth.
The radiotherapy market
in the MEA is predicted to have a slow growth over the forecast period on
account of a lack of awareness regarding chronic diseases as well as treatment
facilities. This region has a slow growth owing to slow economic development, more
illiteracy, and more unskilled labors.
Industry News:
November 2019: Cancer
Research in the UK has come up with a new research network that aims to
increase the development of advanced radiotherapy methods. Scientists will
merge cutting-edge technology with their understanding of cancer biology for
making this treatment more effective and precise than before.
Related Infographics
Links:
Carotid Artery
Disease Market Research Report - Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/carotid-artery-disease-market
Cardiovascular
Information System (CVIS) Market Research Report - Global Forecast till 2025
https://www.marketresearchfuture.com/infographics/cardiovascular-information-system-market
Comments
Post a Comment